PP-037 Comparison of the Effects of Metoprolol or Carvedilol Upon Serum GGT and Uric Acid Levels among the Patients with Acute Coronary Syndrome without ST Segment Elevation




Objective


Serum gamma-glutamyltransferase (GGT) and uric acid levels measured in patients with acute coronary syndrome without ST segment elevation (NSTEMI) are important in the diagnosis and in predicting the prognosis. There is a limited number of clinical studies investigating the effects of beta blockers on GGT and uric acid levels in these patients. In our study we aimed to investigate the effects of beta blocker therapy on GGT and uric acid levels.




Methods


Our study is randomized, prospective clinical study and 100 patients with NSTEMI were included in this study and patients were divided into two groups. 50 patients were administered metoprolol succinate treatment (1×50 mg) while the other 50 patients were administered carvedilol treatment (2×12.5 mg). Afterwards; all of the patients had coronary angiography. Blood samples were taken at the time of admission, at the first month and third month in order to detect GGT and uric acid levels.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. OP-001 An Under-estimated Complication ff Atrial Fibrillation Ablation: Gastroparesis
  2. PP-087 QRS-T Angle is Wider in Patients with Hypertension
  3. PP-119 Treatment of Atrial Fibrillation with Pulmonary Vein Isolation: A Single Center Experience
  4. PP-152 Congenital Cardiac Malformations in Turner Syndrome

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 30, 2016 | Posted by in CARDIOLOGY | Comments Off on PP-037 Comparison of the Effects of Metoprolol or Carvedilol Upon Serum GGT and Uric Acid Levels among the Patients with Acute Coronary Syndrome without ST Segment Elevation

Full access? Get Clinical Tree
Get Clinical Tree app for offline access